Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T19:13:06.715Z.
Calculation as of: 2026-10-06T19:13:06.715Z.
Quote observation: 2026-10-06T19:07:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 75b78fb0f07f9e339fd4071160809690f580f97426e97a581df10cf86c1fdb4f
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Park Dental Partners, Inc. Common Stock
Market Cap
$93.48M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $93.48M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $93.12M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $96.26M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $91.07M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $98.09M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.84M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.56M | 117.02 | 46.83 | 44.28 | 282.12 |
| Rallybio Corporation (RLYB)vs › | $89.74M | 2.17 | 2.16 | 2.16 | 2.16 |
| electroCore, Inc. (ECOR)vs › | $89.89M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
12.5
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$20.70
Forward EPS (Est.)
$1.66
Forward P/E
12.47
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-03-25 | 13.12 |
| 2026-03-24 | 13.03 |
| 2026-03-23 | 13.73 |
| 2026-03-20 | 13.26 |
| 2026-03-19 | 12.67 |
| 2026-03-18 | 13.01 |
| 2026-03-17 | 13.89 |
| 2026-03-16 | 13.87 |
| 2026-03-13 | 13.72 |
| 2026-03-12 | 14.66 |
| 2026-03-11 | 14.64 |
| 2026-03-10 | 14.72 |
| 2026-03-09 | 15.11 |
| 2026-03-06 | 15.96 |
| 2026-03-05 | 15.25 |
| 2026-03-04 | 15.37 |
| 2026-03-03 | 15.52 |
| 2026-03-02 | 15.52 |
| 2026-02-27 | 15.33 |
| 2026-02-26 | 15.77 |
| 2026-02-25 | 16.51 |
| 2026-02-24 | 15.82 |
| 2026-02-23 | 15.18 |
| 2026-02-20 | 15.00 |
| 2026-02-19 | 15.09 |
| 2026-02-18 | 15.21 |
| 2026-02-17 | 15.58 |
| 2026-02-13 | 15.57 |
| 2026-02-12 | 14.94 |
| 2026-02-11 | 15.64 |
| 2026-02-10 | 15.42 |
| 2026-02-09 | 14.33 |
| 2026-02-06 | 13.98 |
| 2026-02-05 | 12.78 |
| 2026-02-04 | 12.29 |
| 2026-02-03 | 12.27 |
| 2026-02-02 | 14.03 |
| 2026-01-30 | 13.25 |
| 2026-01-29 | 14.06 |
| 2026-01-28 | 13.68 |
| 2026-01-27 | 15.74 |
| 2026-01-26 | 15.82 |
| 2026-01-23 | 15.76 |
| 2026-01-22 | 15.73 |
| 2026-01-21 | 15.03 |
| 2026-01-20 | 12.68 |
| 2026-01-16 | 12.29 |
| 2026-01-15 | 12.43 |
| 2026-01-14 | 13.33 |
| 2026-01-13 | 12.55 |
| 2026-01-12 | 12.21 |
| 2026-01-09 | 11.81 |
| 2026-01-08 | 11.63 |
| 2026-01-07 | 11.51 |
| 2026-01-06 | 11.69 |
| 2026-01-05 | 12.39 |
| 2026-01-02 | 12.03 |
| 2025-12-31 | 11.99 |
| 2025-12-30 | 10.08 |
| 2025-12-29 | 12.99 |
| 2025-12-26 | 11.93 |
| 2025-12-24 | 11.31 |
| 2025-12-23 | 10.59 |
| 2025-12-22 | 10.99 |
| 2025-12-19 | 11.46 |
| 2025-12-18 | 11.17 |
| 2025-12-17 | 11.28 |
| 2025-12-16 | 10.92 |
| 2025-12-15 | 11.69 |
| 2025-12-12 | 11.39 |
| 2025-12-11 | 11.43 |
| 2025-12-10 | 11.53 |
| 2025-12-09 | 12.81 |
| 2025-12-08 | 10.74 |
| 2025-12-05 | 10.81 |
| 2025-12-04 | 9.38 |
| 2025-12-03 | 8.33 |